This study demonstrates that, in two different high grade glioma cell lines, NO exposure results in a different ceramide distribution and protein expression. Furthemore, this study highlights specific proteins as possible markers for tumor aggressiveness.
1.INTRODUCTION
Anaplastic astrocitomas and glioblastoma multiforme (GBM) are high grade brain tumors originating from astrocytes 1 ; the latter (WHO grade IV) is the most aggressive, being highly invasive and vascularized, with a median survival lower than one year in the 95% of cases 2 . Due to its aggressiveness, chemoresistence and adverse prognosis, the discovery of new therapeutic agents remains a crucial point. Several efforts have been made to elucidate the GBM molecular gene signatures 3 ; the results demonstrate that frequent gene mutations, located in many genes, including p53, isocitrate dehydrogenase (IDH), phosphatidylinositol 3-kinase (PI3K) phosphatase and tensin homologue (PTEN), as well as an unmethylated O6-methylguanine methyltransferase (MGMT) promoter, contribute to radio-and chemo-resistance and correlate with poor survival. Furthermore, the infiltrative growth of GBM causes tumor recurrence at the margin of the surgical resection area 3 .
Currently, GBM therapy involves the administration of the alkylating agent temozolomide (TMZ) in conjugation with radiotherapy 4 or treatment with Carmustine, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in situ, after resection 5 . Evidences indicate that in gliomas, as in extraglial tumors, the sphingolipid metabolite ceramide (Cer) plays an important role as a tumor suppressor being involved in the action of different chemotherapeutic drugs 6, 7 , nevertheless the ceramide-mediated cell death escape 7, 8 remains a critical point.
To overcome chemoresistance, new agents in combination with chemotherapy have been considered, among these, nitric oxide (NO) has emerged as potent chemosensitizer for glioma treatments [9] [10] [11] . NO is a watersoluble highly reactive free radical, with major roles as a vascular relaxing agent, inhibitor of platelet aggregation and neurotransmitter. It can act as anti-inflammatory, pro-inflammatory or cytotoxic agent, inducing cell death through apoptosis or necrosis. NO concentration plays a fundamental role on its activity, which can be carried out by a cGMP dependent (at low concentration, i.e. nM) or independent (at high concentration, i.e. 1μM) mechanism. A previous study demonstrated that treatments with rapid NO releasing donors PAPANONOate ((Z)-[N-(3-ammoniopropyl)-N-(npropyl) amino]diazen-1-ium-1,2-diolate) inhibited rat C6 glioma cell line growth in a dose dependent-manner (via a cGMP-independent mechanism). This inhibition is accompanied by a rapid and significant increase of ceramide in endoplasmic reticulum (ER), presumably, caused by a reduction of ceramide trafficking from ER to Golgi, blunting its conversion into complex sphingolipids 12, 13 . It is also known that PI3K/Akt (phosphatidylinositol-4,5-bisphosphate 3-kinase/ Protein kinase B) pathway regulates ceramide metabolism through a positive control of the vesicular ER to Golgi transport 14 . Other studies, in ovarian cancer cell, demonstrated that NO donor induced a decrement of Akt phosphorylation causing cell death, suggesting that NO donors have the potential to act as anti-tumoral agents, inhibiting cancer cell signaling and reducing cells viability 15 . In addition, NO may exert an apoptotic effect by increasing ceramide levels through the regulation of metabolic pathways involved in ceramide synthesis or removal 16, 17 . Based on previous results on rat C6 glioma cell line, the aim of this study was to assess the effect of PAPANONOate considering cell proliferation, ceramide trafficking and proteomic signature of CCF-STTG1 and T98G glioma cell lines. Both cell lines derived from human gliomas with different oncogene mutations 3 . CCF-STTG1, as C6 glioma cell line, have PI3K/Akt pathway constitutively activated, the former for mutation in PTEN gene 9, 18 and the latter for lack of PTEN expression 19 , while T98G cell line is mutated in p53 (onco suppressor) 20 .
The differential proteomic analysis was based on two dimensional difference in gel electrophoresis (2D-DIGE), MALDI mass spectrometry, coupled with bioinformatics and immunoblotting, to provide quantitative data characteristic of these two cell lines.
Results indicate that T98G compared to CCF-STTG1 cell line, was more resistant to NO and was characterized by a specific proteomic profile. . PTEN act as negative control of PI3K/Akt signaling pathway through its phosphatase activity. The activation of Akt, expressed by the pAkt/Akt ratio, plays an anti-apoptotic role by inducing the overexpression of the antiapoptotic molecule B-cell-lymphoma 2 (Bcl-2) 21 . In CCF-STTG1 cells, Akt was hyperphosphorylated as indicated by the higher pAkt/Akt ratio and Bcl2 was increased; conversely, in T98G, pAkt/Akt ratio was very low and Bcl2 expression was undetectable.
2.2.Effects of nitric oxide on CCF-STTG1 and T98G cell lines proliferation.
The effect of NO exogenously delivered to CCF-STTG1 and T98G, on cell proliferation, was assessed by cell treatment with different concentrations of NO-releasing molecules PAPANONOate, SNAP or SPNO. In CCF-STTG, exposure to NO-releasing molecules caused a 50% decrease of cell proliferation (Fig. 3A) . On the other hand, the same exposure didn't alter cell proliferation of T98G cells even when PAPANONOate concentration was drastically increased (up to 1 mM) (Fig. 3B ).
2.3.Effects of nitric oxide on ceramide distribution in CCF-STTG1 and T98G cell lines.
The effects of NO release on intracellular ceramide trafficking were qualitatively assessed following the redistribution of C5-BODIPY-Cer, a fluorescent analogue of ceramide, able to mimic the dynamic of the natural molecule. The distribution of ceramide in CCF-STTG1 and T98G cells after NO delivery was determined by fluorescence. Cells were treated with C5-BODIPY-Cer (Fig. 4) , and chased in presence or absence of 0.4 mM PAPANONOate. In CCF-STTG1 untreated cells, fluorescence was accumulated in the perinuclear region, indicatives of the Golgi apparatus, (Fig. 4) , whereas, as previously observed 13 , in NOtreated cells fluorescence was spread throughout the cell with reduced accumulation in the Golgi region (Fig. 4) . By contrast, in T98G NO-treated cells, C5-BODIPY-Cer distribution was similar to control with a prevailing accumulation of fluorescence in the Golgi region (Fig. 4) .
2.4.Proteomic analysis
The CCF-STTG1 cell line showed a partial decrease of proliferation and ceramide accumulation in ER in response to nitric oxide releasing agent PAPANONOate, whereas the T98G cell line was resistant to NO administration.
The 
2.4.1Chaperone and stress response proteins (Fig. 5).
Comparing T98G vs CCF-STTG1 cell lines, the HSPs (Heat shock proteins) and cytoplasmic stress response proteins HSPA4 (heat shock 70 kDa protein 4), HSP90AB1 (Heat shock protein HSP 90-beta), GSTP1
(gluthatione S-transferase P), PRDX1 (peroxiredoxin 1) were more abundant. Conversely, HSP27 (Heat shock protein beta-1) was less abundant and mitochondrial HSPA9 (mortalin) was more abundant in T98G compared to CCF-STTG1. In mitochondria, the interaction of these proteins, promotes the control of apoptosis by binding survivin and p53 22 . Conversely, proteins localized in endoplasmic reticulum, as PDIA3
(protein disulfide isomerase A3), P4HB (protein disulfide isomerase), CALR (calreticulin), GRP78 (78 kDa glucose-regulated protein) and TRA1 (heat shock protein gp96 precursor), were less abundant in T98G cells compared to CCF-STTG1. CALR, PDI, GRP78 and TRA1 are involved in the unfolding protein response (UPR) 23, 24 .
2.4.2.Cytoskeletal proteins and intracellular signal proteins (Fig. 6).
The majority of the cytoskeletal proteins such as: F-actin capping protein beta subunit (CAPZB), Vinculin (VLC), and two isoforms of Vimentin, were less abundant in T98G compared to CCF-STTG1 cell line.
Conversely, moesin (MSN) and the Microtubule-associated protein RP/EB family member 1 (MAPRE1)
were more abundant in T98G cell line.
Among proteins involved in intracellular signaling, Rho GDP-dissociation inhibitor 1 (ARHGDIA) and Rab GDP dissociation inhibitor beta (GDI2) were more abundant in CCF-STTG1 than in T98G.
2.4.3.Protein degradation (Fig. 7).
Comparing the two cell lines, two subunits of the immunoproteasome activator Proteasome activator complex subunit 1 (PSME1), Proteasome activator complex subunit 2 (PSME2) and cathepsin D (CTSD), a lysosomal aspartic protease, were less abundant in T98G. Importantly, ubiquitin carboxy-terminal hydrolase L1 (UCHL1) was more abundant in T98G compared to CCF-STTG1 with a Fold Change of 14.86.
The global expression of metabolic proteins was similar in the two cell lines, with only few exceptions like L-lactate dehydrogenase B chain and transketolase that were more abundant in T98G cell line compared to CCF-STTG1.
Galectin 1 (LGALS1) was less abundant in T98G compared to CCF-STTG1 cell line. Other proteins differentially expressed in T98G vs CCF-STTG1 are listed in table 1S.
2.5.GRP78 expression level and localization (Fig. 8)
The ubiquitously expressed molecular chaperone GRP78 (glucose-regulated protein) is generally localized to the ER (endoplasmic reticulum) and it is specifically induced in cells under UPR (unfolded protein response). Immunoblotting showed that levels of GRP 78 in CCF-STTG1 are twofold those observed in PAPANONOate didn't show modification of their GRP78 level ( Fig 8A) and localization (data not shown).
3.DISCUSSION
CCF-STTG1 and T98G cell lines are multidrug-resistant 26 and NO donors were used to induce growth inhibition and chemosensitization 10 . In the present study exogenous NO, delivered through PAPANONOate treatment, induced a decrease in cell proliferation (<50%) and intracellular trafficking of ceramide in CCF-STTG1 but not in T98G cell line. Results provided by both Akt pathway and ceramide trafficking analyses suggested a similar profile between human CCF-STTG1 and rat C6 glioma cell line 13, 14 ; whereas T98G cell line showed a different profile being Akt-harboring and p53 mutated. In addition, Bcl2, a downstream effectors of Akt, playing a role in the promotion of tumor malignancy, was not expressed in T98G cell line,
suggesting that these cells may adopt alternative mechanisms to growth and proliferate.
Proteomic analysis, by 2D-DIGE and mass spectrometry, highlighted differences between the two cell lines, that could contribute to explain their different responses to NO exposure. Three main protein functional classes were differently regulated in T98G compared to CCF-STTG: chaperones and stress response proteins located in the cytosol and endoplasmic reticulum, cytoskeletal proteins and proteins involved in degradation.
T98G, was characterized by higher expression levels of stress response proteins, chaperones, redox cytosolic enzymes (i.e. HSPA4, HSP90AB1, GSTP1 and PRDX1) and a mitochondrial protein (HSPA9) and by lower expression levels of ER localized proteins (i.e. PDIA3, P4HB, CALR, GRP78 and TRA1) and of cytoskeleton associated proteins (i.e. HSP27).
Physiologically, molecular chaperones (like HSP90 and HSP70) are known to control protein folding, turnover, differentiation and survival. In particular, it is known that their expression is increased under cellular stress, promoting, in tumors, malignant transformation and maintenance of cancer homeostasis even in a hostile environment, as in presence of genetic lesions 27 . In many tumors, the increment of molecular chaperones provides a protection from stress-induced apoptotic signals 28 . In addition, increased GSTP1 and PRDXs has been associated to an increment of cancer incidence and relapse 22. PRDXs are increased in many tumors such as lung, breast cancer, malignant mesothelioma and grade III and IV glioblastomas 27 , promoting 
30, 31
To define the exact role of these molecules further analysis will be required since the effects of PDI in supporting tumor survival and progression could be cell-and cancer-type dependent. The UPR response, in fact, occurs when miss-folded proteins accumulate in ER, generating ER stress, which leads to an increment of ER chaperone proteins, accompanied by a temporary blockage of protein translation and by the activation of ERAD (endoplasmic reticulum associated degradation) complex 23 . In T98G, the levels of proteins controlling the UPR response were lower compared to CCF-STTG1. Elevated protein synthesis, in cancer cell, requires an increase of ER folding, thus an UPR increase in cancer cell (i.e. up regulation of ER chaperones) could provide an advantage for cell proliferation inducing chemoresistance 24 . Nevertheless, the prolonged and severe activation of UPR leads to cell death by apoptosis. These results could be supportive of a mild activation of UPR that could be an adaptive response, as suggested by T98G cell line behavior 32 .
Indeed, in CCF-STTG1 cells, NO treatment increases ER stress 33 , promoting ER functional impairment, which, in turn, compromises, at least partially, the delivery of ceramide from ER to Golgi, with a consequent ceramide accumulation in ER and growth arrest.
The dysregulation of proteins involved in cytoskeletal structure remodeling (i.e vinculin, moesin and vimentin) and of regulatory proteins (i.e. HSP27, MAPRE1 and ARHGDIA) can be associated with the cytoskeletal reorganization, prominent in T98G compared to CCF-STTG1 cell line. Vimentin, a marker of EMT (epithelial-mesenchymal transition or transformation) overexpressed in cancer cells 34 , was significantly less abundant in T98G compared to CCF-STGG1 cell lines. Moreover moesin (MSN), involved in actin cytoskeleton control and cell migration, known to promote GBM proliferation and invasiveness 35 , and the Microtubule-associated protein RP/EB family member 1 (MAPRE1), a master regulator of the microtubule 36 were more abundant in T98G cell line. It can be assumed that, in T98G cells, this decrement may be due to a higher protein catabolism instead of a decreased synthesis. This hypothesis is supported by the low levels of heat shock proteins (HSP27 was less abundant in T98G than CCF-STTG1) and by cell turnover rate of T98G 26 , which induces a persistent remodeling of structural proteins.
Rho family-Rho GDI system plays a crucial role in actin cytoskeletal control and its down-regulation leads to Rho GTPases activation signaling 37 . The insensitivity to NO of T98G cells may be due to a decrement of GDI2, a negative regulator of the monomeric G protein Rab GTPases which inhibits the exchange of GDP to GTP, stabilizing Rab proteins associated to GDP. Rab proteins are involved in the vesicular trafficking within cells, particularly Rab1 and Rab2 are implicated in endoplasmic reticulum to Golgi apparatus transport 38 . The negative regulator GDI2 may contribute to blunt the sensitivity of T98G to nitric oxide on ceramide distribution by affecting the ceramide vesicular transport between intracellular compartments.
Finally, also levels of PSME1, PMSE2 , cathepsin D, acting as regulators of proteasomal degradation and promoters of oxidative stress adaptation 39, 40 and Galectin 1 have been found altered.
Galectin 1 has been found dysregulated in many tumors including astrocytoma, melanoma, prostate, colon and ovary carcinomas and is often correlated with tumor aggressiveness and metastatization 37 . In T98G cells, the above proteins, were less abundant compared to CCF-SSTG1, suggesting that due to the partial effect of NO in CCF-STTG1 (50% decrement of cell proliferation), treatments able to modulate these proteins/pathways should be associated to NO donors to improve treatment response.
Furthermore, the differential expression between T98G and CCF-STTG1 of ubiquitin carboxy-terminal hydrolase L1 (UCHL1),more abundant in T98G (Fold Change +14.86), has to be considered. The overexpression of UCHL1 leads to a down regulation of E-cadherin and consequently anoikis resistance, independent growth, anchoring and spreading. UCHL1 regulates key processes in tumor progression and, particularly, the signaling of β-catenin/TCF stabilizing the latter by de-ubiquitination. The β-catenin/TCF mediates the expression of genes like c-myc, cyclin D, c-jun, and survivin and others that are part of the oncogenic pathway. Growing evidence suggest that UCHL1 is overexpressed in many tumors and is associated with a poor prognosis 38 . Recent results demonstrate that the selective inhibition of UCHL1 by small molecules and siRNA causes a decrease in tumor proliferation and migration and increases the chemotherapeutic agents sensitivity inducing apoptosis 41 .
Overall these results suggest that nitric oxide treatment is a potential anti-oncogenic agent that could overcome the resistance to conventional therapeutic agents in some cancer cells. NO releasing donor, PAPANONOate, causes ceramide accumulation in CCF-STTG1 cell lines. This accumulation, can induce a switching of Akt hyperactivated signal 14, 42 , causing growth inhibition. From proteomic data, the UPR stress response was more pronounced in CCF-SSTG1 than T98G, and this feature could interfere with ER and Golgi trafficking , in particular under nitric oxide stress. 
4.MATERIALS AND METHODS

Materials
4.1.Cell Cultures
Two human glioblastoma cell lines were used: the cell line CCF-STTG1, p53 wild type and PTEN mutated, and the T98G cell line p53 mutated and PTEN wild type obtained from American Type Culture Collection (Rockville, MD. The two cell lines were grown at 37°C in DMEM supplemented with 10% FCS, 1 mM sodium pyruvate, 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin and 0.25 μg/ml amphotericin B in a fully humidified incubator containing 5% CO 2 and 95% air. For proteomic analysis 2D-DIGE, CCF-STTG1 and T98G cells were plated (6 x 10 4 cells/cm 2 and 1.5x104 cells/cm 2 respectively) and maintained in DMEM plus 10% FCS for 72 h.
4.2.Proliferation assay
CCF-STTG1 and T98G, cells were plated (6 x 10 4 cells/cm BrdU incorporated was detected using a microplate reader (Wallac Victor2 from PerkinElmer).
4.3.Analysis of the Intracellular Distribution of Fluorescent Ceramides
CCF-STTG1 and T98G cells plated at 4.5x104 cell/cm2 and 1.5x104 cell/cm2 respectively were grown on a glass coverslip. Then cells were incubated with 5 μM BODIPY-C5-Cer (as 1:1 complex with fatty acid free BSA) in DMEM at 4°C for 30 min and analyzed as previously described 13 . Briefly, after washing, with DMEM plus 10%FCS and 0.34 mg/ml fatty acid-free BSA, cells were incubated 1 h at 37 °C in DMEM plus 10%FCS with or without PAPANONOate. Cells were then washed and fixed with 0.5% glutaraldehyde solution in PBS for 10 min at 4 °C. The specimens were immediately observed and analyzed with a fluorescence microscope (Olympus BX-50) equipped with a fast high resolution charge-coupled device camera (Colorview 12) and dedicated software for images analysis (Analysis from Soft Imaging System GmbH).
4.4.Proteomic analysis.
4.4.1.Two dimensional difference in gel electrophoresis (2D-DIGE)
Protein labeling, 2D separation and analysis were performed as previously described 43 . The pellet of each sample was suspended in lysis buffer, assayed and labelled with the CyDye fluorophores. A common internal standard for the two cell lines was created. The internal standard was labeled with Cy3, while samples were labeled with Cy5 and analyzed in triplicate. The first dimension was performed on IPGstrip3-10 nonlinear (NL) immobilized pH gradient, 24 cm long, each strip was loaded with 40 μg of internal standard and 40 μg of sample. Gel images were processed by a 2D DeCyder software for the quantitative analysis. Statistically significant differences of 2D-DIGE data were computed by Student's t-test (p < 0.01).
To minimize false-positives, data were filtered by the following criteria: False Discovery Rate (FDR) and 1.5
fold difference in abundance (Fold Change). FDR correction was applied as multiple test for the correction method to keep the overall error rate as low as possible 44 . The Fold Change, provided by DeCyder software analysis, indicates the value derived from the normalized spot volume standardized against the intra-gel standard.
4.4.2.Protein identification by MALDI-ToF mass spectrometry.
Proteins were identified by peptide mass fingerprinting (PMF) utilizing a matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometer (Bruker Daltonics), as previously described 43 . In particular, search was carried out by correlation of uninterpreted spectra to Mammalia entries in NCBInr 20070216 database (4626804 sequences; 1596079197 residues).
4.4.3Bioinformatic data analysis of molecular pathways
The MetaCore software (GeneGo, Inc., V6.3 build 25177), using two different bioinformatics analyses (''Enrichment Ontologies'' and ''Analyze Network''), was used to the interpretation of differential protein expression from CCF-STTG1 and T98G cell lines and for search protein-protein interaction networks.
4.5.Immunoblottings
Protein extracts (50 μg) from CCF-STTG1 and T98G cell lines were loaded in triplicate and resolved on 
5.CONCLUSIONS
Nitric oxide is emerging as a potential anti-oncogenic agent to overcome chemo-and radio-resistance in cancer cells; although its actions depend on the cell microenvironment. The treatment with the NO donor, PAPANONOate, is able to partially reduce the proliferation of CCF-STTG1, suggesting that NO alone is not sufficient to inhibit the tumor cell growth. In CCF-SSTG1, an overexpression of proteins located in the endoplasmic reticulum and involved in the unfolded protein response was observed, making this cell line sensible to NO. By contrast, in T98G cell line, a complex of cytosolic anti-oxidant and stress response proteins provides resistance to NO activity. This study, by providing differential ceramide distribution and differential protein expression, following NO exposure, identifies specific proteins as possible tumor aggressiveness markers of two human high grade glioma cell lines.
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Figure legends PAPANONOate (NOC15). Representative fluorescence microscopy images are shown. All images were processed and printed using the same conditions. Scale bar, 20 μm. Immunoblotting of GRP78 on CCF-STTG1 and T98G cells before and after PAPANONOate treatment.
Histograms represent the mean volumes and the standard deviations calculated for the specific band of each experimental group. Data with asterisks indicates significant differences between two cell lines with a p value < 0.05 (panel A).
Effect of NO on intracellular GRP78 localization. CCF-STTG1 and T98G cells grown on a glass coverslip were incubated at 37°C for 4 h with and without 400μM PAPANONOate. Cells were stained with anti-GRP78 antibody followed by FITC-conjugated secondary antibody. Representative fluorescence microscopy images are shown. All images were processed and printed using the same conditions. Scale bar, 20 μm (panel B). 
